Related Experiment Video
Updated: Mar 30, 2026
06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
13.0K
Assessing Direct Vascular Actions of Estrogens
Douglas S Martin1, Kathleen M Eyster2
1Division of Basic Biomedical Sciences, Sanford School of Medicine, University of South Dakota, 414 E. Clark Street, Vermillion, SD, 57069, USA. Doug.Martin@usd.edu.
Methods in Molecular Biology (Clifton, N.J.)
|November 21, 2015
Summary
Investigating how estrogens impact blood vessels requires studying their direct effects. This chapter details two key methods: the McGregor preparation and the isolated perfused/pressurized vessel approach, for assessing estrogenic substances on vascular function.
Area of Science:
- Vascular Biology
- Endocrinology
- Pharmacology
Background:
- Estrogens are recognized for their significant influence on vascular function.
- Understanding the precise mechanisms requires direct investigation of estrogenic substances on blood vessels.
Purpose of the Study:
- To describe established methodologies for assessing the direct vascular effects of estrogenic substances.
- To highlight the importance of these methods in estrogen-vasculature research.
Main Methods:
- Isolated perfused intact mesenteric vascular bed (McGregor preparation): Assesses vascular reactivity via changes in perfusion pressure under constant flow.
- Isolated perfused/pressurized vessel approach: Utilizes a single vessel mounted on micropipettes, measuring vascular diameter.
Main Results:
- Both the McGregor preparation and the isolated perfused/pressurized vessel approach are validated methods for studying estrogenic effects.
- These techniques allow for direct assessment of estrogenic substances on vascular tissue.
Conclusions:
- The McGregor preparation and isolated perfused/pressurized vessel approach are fundamental techniques in the field.
- These methods are crucial for advancing the understanding of direct estrogenic actions on blood vessels.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
4.0K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
01:26Secondary Messengers in Hormone Action
6.2K
Water-soluble hormones cannot cross the plasma membrane, so they rely on protein receptors that span the membrane to trigger intracellular signaling pathways. These pathways then activate second messengers inside the cell, including cAMP or calcium ions.
Many hormones bind to transmembrane G protein-coupled receptors that connect to regulatory G proteins. These G proteins can then activate enzymes such as adenylyl cyclase or phospholipase C. Adenylyl cyclase converts ATP to cAMP, activating...
Many hormones bind to transmembrane G protein-coupled receptors that connect to regulatory G proteins. These G proteins can then activate enzymes such as adenylyl cyclase or phospholipase C. Adenylyl cyclase converts ATP to cAMP, activating...
6.2K
01:16Vascular Spasm
4.8K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
4.8K
01:22Target Cell Response to Hormones
6.2K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
6.2K
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
607
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
607
01:23Antihypertensive Drugs: Vasodilators
2.5K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.5K